| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial KC Wollert, GP Meyer, J Lotz, SR Lichtenberg, P Lippolt, C Breidenbach, ... The Lancet 364 (9429), 141-148, 2004 | 3213 | 2004 |
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST … GP Meyer, KC Wollert, J Lotz, J Steffens, P Lippolt, S Fichtner, H Hecker, ... Circulation 113 (10), 1287-1294, 2006 | 1410 | 2006 |
| Monitoring of bone marrow cell homing into the infarcted human myocardium M Hofmann, KC Wollert, GP Meyer, A Menke, L Arseniev, B Hertenstein, ... Circulation 111 (17), 2198-2202, 2005 | 1216 | 2005 |
| The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury T Kempf, M Eden, J Strelau, M Naguib, C Willenbockel, J Tongers, ... Circulation research 98 (3), 351-360, 2006 | 897 | 2006 |
| Clinical applications of stem cells for the heart KC Wollert, H Drexler Circulation research 96 (2), 151-163, 2005 | 633 | 2005 |
| Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure T Kempf, S von Haehling, T Peter, T Allhoff, M Cicoira, W Doehner, ... Journal of the American College of Cardiology 50 (11), 1054-1060, 2007 | 621 | 2007 |
| Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study TJ Wang, KC Wollert, MG Larson, E Coglianese, EL McCabe, S Cheng, ... Circulation 126 (13), 1596-1604, 2012 | 578 | 2012 |
| GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice T Kempf, A Zarbock, C Widera, S Butz, A Stadtmann, J Rossaint, ... Nature medicine 17 (5), 581-588, 2011 | 555 | 2011 |
| Growth differentiation factor 15 as a biomarker in cardiovascular disease KC Wollert, T Kempf, L Wallentin Clinical chemistry 63 (1), 140-151, 2017 | 541 | 2017 |
| Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome C Widera, SK Gupta, JM Lorenzen, C Bang, J Bauersachs, K Bethmann, ... Journal of molecular and cellular cardiology 51 (5), 872-875, 2011 | 533 | 2011 |
| Prognostic value of growth-differentiation factor-15 in patients with non–ST-elevation acute coronary syndrome KC Wollert, T Kempf, T Peter, S Olofsson, S James, N Johnston, B Lindahl, ... Circulation 115 (8), 962-971, 2007 | 505 | 2007 |
| Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy: ASSEMBLY OF SARCOMERIC UNITS IN SERIES VIA gp130/LEUKEMIA INHIBITORY FACTOR RECEPTOR-DEPENDENT … KC Wollert, T Taga, M Saito, M Narazaki, T Kishimoto, CC Glembotski, ... Journal of Biological Chemistry 271 (16), 9535-9545, 1996 | 493 | 1996 |
| Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury D Hilfiker-Kleiner, A Hilfiker, M Fuchs, K Kaminski, A Schaefer, B Schieffer, ... Circulation research 95 (2), 187-195, 2004 | 459 | 2004 |
| Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial GP Meyer, KC Wollert, J Lotz, J Pirr, U Rager, P Lippolt, A Hahn, ... European heart journal 30 (24), 2978-2984, 2009 | 415 | 2009 |
| Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial IS Anand, T Kempf, TS Rector, H Tapken, T Allhoff, F Jantzen, ... Circulation 122 (14), 1387-1395, 2010 | 397 | 2010 |
| Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new … T Kempf, R Horn-Wichmann, G Brabant, T Peter, T Allhoff, G Klein, ... Clinical chemistry 53 (2), 284-291, 2007 | 369 | 2007 |
| Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes B Fiedler, SM Lohmann, A Smolenski, S Linnemüller, B Pieske, ... Proceedings of the National Academy of Sciences 99 (17), 11363-11368, 2002 | 345 | 2002 |
| Cell therapy for the treatment of coronary heart disease: a critical appraisal KC Wollert, H Drexler Nature Reviews Cardiology 7 (4), 204-215, 2010 | 324 | 2010 |
| Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction T Kempf, E Björklund, S Olofsson, B Lindahl, T Allhoff, T Peter, J Tongers, ... European heart journal 28 (23), 2858-2865, 2007 | 310 | 2007 |
| Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the … L Lind, L Wallentin, T Kempf, H Tapken, A Quint, B Lindahl, S Olofsson, ... European heart journal 30 (19), 2346-2353, 2009 | 300 | 2009 |